Factors associated with disease progression in patients treated with trametinib in combination with dabrafenib for unresectable advanced BRAFV600-mutant melanoma: An open label, non randomized study

Affiliation auteurs!!!! Error affiliation !!!!
TitreFactors associated with disease progression in patients treated with trametinib in combination with dabrafenib for unresectable advanced BRAFV600-mutant melanoma: An open label, non randomized study
Type de publicationJournal Article
Year of Publication2019
AuteursSaiag P., Robert C., Grob J.J, Mortier L., Dereure O., Lebbe C., Mansard S., Grange F., Neidhardt E-M., Lesimple T., Machet L., Bedane C., Maillard H., Dalac-Rat S., Nardin C., Szenik A., Denden A., Dutriaux C.
JournalANNALS OF ONCOLOGY
Volume30
Pagination546
Date PublishedOCT
Type of ArticleMeeting Abstract
ISSN0923-7534